Hong Kong · Sponsored
Tolerability of COVID-19 vaccines in patients with cancer
This content is sponsored. It is intended for healthcare professionals only.
SARS-CoV-2 virus is the causative agent of Coronavirus Disease 2019 (COVID-19) and has infected many over the past two-and-a-half years, including healthy people and those with underlying co-morbidities such as the immunocompromised. Following the administration of COVID-19 vaccines from late 2020 onwards, severe and critical COVID-19 outcomes decreased by over 60%.
